Eli Lilly

IRS: 350470950
LLY
Eli Lilly

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Founded
1901 (121 years)
Investor RelationsSEC
Revenue
29 billion (2022)

Want to see more? Sign up!